Full Length Research Paper
References
|
Alexieva B, Sainova I, Pavlova V, Markova T, Valkova I, Nikolova E (2014). Insights into Mechanisms of Doxorubicin Cardiotoxicity. J. Phys. Pharm. Adv. 4(3):342-348. |
|
|
Amidon GL, Lennernas H, Shah VP, Crison JR (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413-420. |
|
|
Boobis A, Gundert-Remy U, Kremers P, Macheras P, Pelkonen O (2002). In silico prediction of ADME and pharmacokinetics: Report of an expert meeting organised by COST B15. Eur. J. Pharm. Sci. 17(4):183-193. |
|
|
Butina D, Segall MD, Frankcombe K (2002). Predicting ADME properties in silico: methods and models. Drug Discov. Today 7(11):S83-S88. |
|
|
Choudhary MI, Jalil S, Nawaz SA, Khan KM, Tareen RB (2009). Anti-inflammatory and lipooxygenase inhibitory compounds from vitex agnus-castus. Phytother Res. 23(9):1336-1339 |
|
|
Comerford SC (1996). Medicinal plants of two Mayan healers from San Andŕes, Peten, Guatemala. Econ. Bot. 50:327-336. |
|
|
Coussens LM, Werb Z (2002). Inflammation and cancer. Nature 420(6917):860-867. |
|
|
Coussens LM, Zitvogel L, Palucka AK (2013). Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339(6117):286-291. |
|
|
Dahan A, Miller JM (2012). The solubility–permeability interplay and its implications in formulation design and development for poorly soluble drugs. AAPS J. 14(2):244-251. |
|
|
Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN, Ray C (1968). Screening of Indian plants for biological activity: I. Indian J Exp. Biol. 6(4):232-247. |
|
|
Elufioye TO, Oladele AT, Cyril-Olutayo CM, Agbedahunsi JM, Adesanya SA (2012). Ethnomedicinal study and screening of plants used for memory enhancement and antiaging in Sagamu, Nigeria. Eur. J Med Plants 2(3):262. |
|
|
Encarnacion DR, Virgen M, Ochoa N (1998). Antimicrobial activity of medicinal plants from Baja California Sur (Mexico). Pharm. Biol. 36:33-43. |
|
|
Eneji SM, Inuwa HM, Ibrahim S, Ibrahim AB Abdulfattah A (2011). In vitro assessment of bioactive components of Mirabilis jalapa ethanolic extract on clinical isolates of Salmonella typhi and Bacillus cereus. Afr. J. Biotechnol. 10(71):16006-16011. |
|
|
Ghafourian T, Amin Z (2013). QSAR models for the prediction of plasma protein binding. BioImpacts 3(1):21-27. |
|
|
Harvey AL (2008). Natural products in drug discovery. Drug Discov. Today 13(19):894-901. |
|
|
Holdsworth DK (1992). A preliminary study of medicinal plants of Easter Island, South Pacific. Int. J. Pharmacogn. 30:27-32. |
|
|
Kapetanovic IM (2008). Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. Chem. Biol. Interact. 171(2):165-176. |
|
|
Li-Jia L, Xiu-Wen W, Ru-Feng W, Yu-Shuai P, Xin Y, Jun-Xiu L (2014). Absorption properties and mechanism of trolline and veratric acid and their implication to an evaluation of the effective components of the flowers of Trollius chinensis. Chin. J. Nat. Med. 12(9):700-704. |
|
|
Mantovani A, Savino B, Locati M, Zammataro L, Allavena P, Bonecchi R (2010). The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev. 21(1):27-39. |
|
|
McNaughton R, Huet G, Shakir S (2014). An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision-making. BMJ Open 4(1):e004221. |
|
|
Mikhailovskii A G, Shklyaev VS (1997). Pyrrolo [2, 1-a] isoquinolines (review). Chem. Heterocycl. Compd. 33(3):243-265. |
|
|
Moroy G, Martiny VY, Vayer P, Villoutreix BO, Miteva MA (2012). Toward in silico structure-based ADMET prediction in drug discovery. Drug Discov. Today 17(1):44-55. |
|
|
Muthumani M, Devi P, Meera R, Kameswari B, Eswarapriya B (2010). In vitro antimicrobial activity of various extracts of Mirabilis jalapa leaves. Int. J. Microbiol. 7(2):120-124. |
|
|
Nair R, Kalariyat T, Chanda S (2005). Antibacterial activity of some selected Indian medicinal flora. Turk. J. Biol. 29:41-47. |
|
|
Nath LR, Manjunath KP, Savadi RV Akki KS (2010). Anti-inflammatory activity of Mirabilis jalapa linn. Leaves. J. Basic Clin. Pharm. 1(2):93-96. |
|
|
National Center for Biotechnology Information (NCBI) (2016). PubChem Compound Database; CID=31703, Available at: https://pubchem.ncbi.nlm.nih.gov/compound/31703#section=Top Accessed Jan. 18, 2016. |
|
|
Newman DJ, Cragg GM (2012). Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75(3):311-335. |
|
|
Oladunmoye M (2012). Antioxidant, free radical scavenging capacity and antimicrobial activities of Mirabilis jalapa. J. Med. Plants Res. 6(15):2909-2913. |
|
|
Onakpoya IJ, Heneghan CJ, Aronson JK (2015). Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysis. BMC Med. 13(1):26. |
|
|
Patel SK, Kumar D, Waghmode AP, Dhabale AS (2011). Solubility enhancement of ibuprofen using hydrotropic agents. Int. J. Pharm. Life Sci. 2(2):542-545. |
|
|
Roberts JA, Pea F, Lipman J (2013). The clinical relevance of plasma protein binding changes. Clin. Pharmacokinet. 52(1):1-8. |
|
|
Saiakhov RD, Stefan LR, Klopman G (2000). Multiple computer-automated structure evaluation model of the plasma protein binding affinity of diverse drugs. Perspect. Drug Discov. Des.19(1):133-155. |
|
|
Scheife RT (1989). Protein binding: what does it mean? Ann. Pharmacother. 23(7-8)-S27-S31. |
|
|
Shaik S, Rajendra Y, Jaya Chandra Reddy P (2012). Phytochemical and pharmaclogical studies of mirabilis jalapa linn. Int. J. Pharm Technol. 4(2):2075-2084. |
|
|
Siddiqui BS, Adil Q, Begum S, Siddiqui S (1994) Terpenoids and steroids of the aerial parts of Mirabilis jalapa Linn. Pak. J. Sci. Ind. Res. 37:108-110. |
|
|
Singh M, Mittal SK (2012). Mirabilis Jalapa-A Review. Int. J. Pharmaceut. Med. Appl. Sci. 1(3):22-43. |
|
|
Taylor L (2005). The healing power of rainforest herbs. Tropical Plant Database. http://www.rain-tree.com. Accessed 11th April, 2016. |
|
|
Walker CIB, Trevisan G, Rossato MF, Franciscato C, Pereira ME, Ferreira J, Manfron MP (2008). Antinociceptive activity of Mirabilis jalapa in mice. J. Ethnopharmacol. 120(2):169-175. |
|
|
Wang RF, Yang XW, Ma CM, Cai SQ, Li JN, Shoyama Y (2004). A bioactive alkaloid from the flowers of Trollius chinensis. Heterocycles 63(6):1443-1448. |
|
|
Wang YF, Chen JJ, Yang Y, Zheng YT, Tang SZ, Luo SD (2002). New rotenoids from roots of Mirabilis jalapa. Helv. Chim. Acta 85(8):2342-2348. |
|
|
Wong RN, Ng TB, Chan SH, Dong TX, Yeung HW (1992). Characterization of Mirabilis antiviral protein--a ribosome inactivating protein from Mirabilis jalapa L. Biochem. Int. 28(4)585-593. |
|
|
Xu JJ, Chen Qing, Lv YP, Liu YM, Liu Y, Ye-Gao Chen (2010). Cytotoxic rotenoids from Mirabilis jalapa. Chem. Nat. Compd. 46(5):792. |
|
|
Yang Z, Liu C, Xiang L, Zheng Y (2009). Phenolic alkaloids as a new class of antioxidants in Portulaca oleracea. Phytother. Res. 23(7):1032-1035. |
|
|
Yu H, Adedoyin A (2003). ADME–Tox in drug discovery: integration of experimental and computational technologies. Drug Discov. Today 8(18):852-861. |
|
|
Zhao YX, Ding XB (2004). Studies on the alkaloids from Salsola collina Pall. Acta Pharm. Sin. B. 39(8):598-600. |
|
|
Zhou J, Chan L, Zhou S (2012). Trigonelline: A plant alkaloid with therapeutic potential for diabetes and central nervous system disease. Curr. Med. Chem. 19(21):3523-3531. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
